Malawi
With the tenth highest proportion of people living with HIV and eleventh highest amount of AIDS-related deaths globally, Malawi has struggled with tackling this epidemic that has orphaned millions of children and contributed to the overwhelmingly young distribution of the population under 24 years (67%).
JSI has worked in Malawi for over 25 years to strengthen health systems in Malawi, including providing HIV&AIDS commodities through JSI’s flagship supply chains and logistics project, The USAID | DELIVER PROJECT. The project supported USAID's efforts to improve product availability by bolstering integrated in-country supply chains, avian and pandemic influenza preparedness, and the President's Malaria Initiative (PMI). In addition to HIV&AIDS commodities, the project addressed a number of critical public health priorities, including childhood pneumonia, malaria prevention, and supply chain systems for family planning, malaria, and essential medicines.
JSI, under USAID’s Maternal and Child Survival Program (MCSP), supported the Ministry of Health/Expanded Program of Immunizations to successfully introduce two vaccines (Measles Rubella and the Inactivated Polio Vaccine); implemented Reaching Every Community (REC) in two priority districts; mobilized children and tracked their immunization status using My Village My Home interactive tool; and built capacity for service providers through training health workers and health management teams.
Most recently, Strengthening Partnerships, Results, and Innovations in Nutrition Globally (SPRING) conducted field research in four countries to develop guidance documentation for a new nutrition-sensitive agricultural indicator required by the U.S government’s Feed the Future Initiative. For Malawi, one of the key recommendations SPRING made was to strengthen farmers’ record-keeping practices to develop their business sense when managing agricultural production and also to generate more reliable and accurate data.
Highlights
DREAMS Innovation Challenge Funds Manager
JSI builds the capacity and monitors the progress of 46 organizations that received DREAMS Innovation Challenge sub-awards to reduce HIV infection in young women in Africa who have limited or no access to health care services.
Blog: Delivering life-saving medicines through mobile
In a piece written for the UN Foundation Global Accelerator blog, SC4CCM project director Yasmin Chandani shares how cStock, a mobile- and web-based logistics monitoring and reporting tool is transforming child health outcomes in Malawi.
Strengthening High Impact Interventions for an AIDS-free Generation (AIDSFree)
Through the AIDSFree project, JSI provides capacity development and technical support to USAID missions, host-country governments, and HIV implementers at the local, regional, and national levels.
Video: Saving the lives of children under five through supply chain innovations
Watch a video to find out how the Supply Chain for Community Case Management (SC4CCM) is improving the supply chain of essential medicines and vaccines for children under five at the community level.
Maternal and Child Survival Program
Under USAID's flagship Maternal and Child Survival Program, JSI leads the child health,immunization, and pediatric HIV activities.
Two Ministry of Health employees receive logistical training from the USAID DELIVER PROJECT and are empowered to improve the quality and efficiency of the health system supply chain in Malawi.
Advancing Partners & Communities
JSI is supporting and advancing community programs in more than 30 countries that seek to improve local health services, especially those related to family planning.
Supply Chain Support for the International Trachoma Initiative
Trachoma, an infectious eye disease, is the world's leading cause of preventable blindness. JSI is providing technical and logistics support to the International Trachoma Initiative, to treat infected populations with azithromycin.
JSI identifed, demonstrated, and institutionalized supply chain management practices that improve availability and use of essential medicines for treating children in community-based programs, to reduce mortality among children under 5 years old.